Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma

BACKGROUND: Classical patient and tumour characteristics are the benchmark of personalised breast cancer (BC) management. Recent evidence has demonstrated that immune and molecular profiling of BC may also play an important role. Despite evidence of differences between invasive ductal (IDC) and lobu...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Engels, C C, Fontein, D B Y, Kuppen, P J K, de Kruijf, E M, Smit, V T H B M, Nortier, J W R, Liefers, G J, van de Velde, C J H, Bastiaannet, E
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 2014
Soggetti:
Molecular Diagnostics
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4119991/
https://ncbi.nlm.nih.gov/pubmed/24937677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.338
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi